Opportunities and challenges for those investing and operating in the life sciences industry
Join West Monroe Partners at McDermott Will & Emery's 2012 Life Sciences Private Equity Dealmaking Symposium.

This inaugural event will focus on the opportunities and challenges for those investing and operating in the multibillion dollar life sciences industry.  A seasoned panel of private equity, pharmaceutical, biotechnology, medical products and services leaders will provide insight and guidance into how to address the ever-changing landscape.  Symposium attendees will include private equity managing directors, investment bankers and C-level executives from medical device, pharmaceutical, diagnostics and other medical products industry participants.

West Monroe will be speaking on the panel "Executing and Financing Carve-Outs from Life Sciences Companies." Carve-outs are becoming increasingly common as life sciences companies examine core assets and refocus on best practices in preparing a division or product line for divestiture. The panel will discuss how to assess transition services, intellectual property, accounting and staffing issues as well as how lenders assess a carve-out transaction. Access the full agenda here.

The event is being held at the JW Marriott Chicago.